ACTRN12609001013257尚未招募2 期
An open-label trial to evaluate the effect of the psychostimulant Methylphenidate on the severity of Borderline Personality Disorder in Adolescents.
Concord Hospital, Department of Psychiatry0 个研究点目标入组 30 人开始时间: 2009年11月23日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
- 盲法
- Open (masking not used)
入排标准
- 年龄范围
- 12 Years 至 18 Years（—）
- 性别
- Female
入选标准
- •Adolescent females with a diagnosis of Borderline Personality Disorder
排除标准
- •- Comorbid diagnosis of Autistic Spectrum Disorder, clinically evident mental retardation or a tick disorder.
- •- Comorbid diagnosis of a significant medical disorder, such as active hepatic or renal disease, dementia, serious head injury or active cancer.
- •- Marked previous or current anxiety or psychotic symptoms.
研究者
相似试验
尚未招募
不适用
A clinical trial to study the effects of atorvastatin in patients with chronic obstructive pulmonary disease.CTRI/2012/11/003162Dr Manisha Bisht60
招募中
2 期
An Open labeled study in efficacy of add-on Ayurveda intervention in comparison with standard in Covid-19 patients with moderate severity and with type 2 diabetes followed by 60 day follwo-upCTRI/2020/12/029985AVP Research Foundation
已完成
2 期
Management of Hair Fall through Rovaan Poshaka TailaCTRI/2020/01/022718Multani Pharmaceuticals Ltd50
尚未招募
Unknown
To evaluate the efficacy of medicated enema therapy and external oleation therapy followed by oral medication in the management of hip joint pain.CTRI/2024/07/070233ational Institute of Ayurveda
Unknown
2 期
Management Madhumeha (Diabetes mellitus type 2)CTRI/2020/01/022662Multani Pharmaceuticals Ltd